Literature DB >> 26538392

MicroRNA-15b/16 Enhances the Induction of Regulatory T Cells by Regulating the Expression of Rictor and mTOR.

Yogesh Singh1, Oliver A Garden2, Florian Lang3, Bradley S Cobb4.   

Abstract

CD4(+) regulatory T cells (Tregs) are essential for controlling immune responses and preventing autoimmunity. Their development requires regulation of gene expression by microRNAs (miRNAs). To understand miRNA function in Treg development, we searched for important miRNAs and their relevant target genes. Of the more abundantly expressed miRNAs in Tregs, only miR-15b/16, miR-24, and miR-29a impacted the production of in vitro-induced Tregs (iTregs) in overexpression and blocking experiments. miRNA mimics for these significantly enhanced the induction of iTregs in Dicer(-/-) CD4(+) T cells. Furthermore, the overexpression of miR-15b/16 in conventional CD4(+) T cells adoptively transferred into Rag2(-/-) mice increased the in vivo development of peripheral Tregs and diminished the severity of autoimmune colitis. In searching for targets of miR-15b/16, we observed that the mammalian target of rapamycin (mTOR) signaling pathway was enhanced in Dicer(-/-) CD4(+) T cells, and its pharmacological inhibition restored induction of iTregs. Suppression of mTOR signaling is essential for induction of iTregs from naive CD4(+) T cells, and the mTORC2 component, Rictor, contained a functional target site for miR-15b/16. Rictor was more abundantly expressed in Dicer(-/-) T cells as was mTOR, and their expression was downregulated by the overexpression of miR-15b/16. This led to a reduction in mTOR signaling, as measured by phosphorylation of the downstream target, ribosomal protein S6. Finally, knockdown of Rictor by small interfering RNAs enhanced Treg induction in Dicer(-/-) CD4(+) T cells. Therefore, an important mechanism of miRNA regulation of Treg development is through regulation of the mTOR signaling pathway.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26538392      PMCID: PMC4671309          DOI: 10.4049/jimmunol.1401875

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.

Authors:  Margaret S Ebert; Joel R Neilson; Phillip A Sharp
Journal:  Nat Methods       Date:  2007-08-12       Impact factor: 28.547

3.  miR-15 and miR-16 induce apoptosis by targeting BCL2.

Authors:  Amelia Cimmino; George Adrian Calin; Muller Fabbri; Marilena V Iorio; Manuela Ferracin; Masayoshi Shimizu; Sylwia E Wojcik; Rami I Aqeilan; Simona Zupo; Mariella Dono; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-Gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-15       Impact factor: 11.205

4.  Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.

Authors:  Jun Wei; Omar Duramad; Olivia A Perng; Steven L Reiner; Yong-Jun Liu; F Xiao-Feng Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

5.  Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Daniel T Patton; Oliver A Garden; Wayne P Pearce; Louise E Clough; Clare R Monk; Eva Leung; Wendy C Rowan; Sara Sancho; Lucy S K Walker; Bart Vanhaesebroeck; Klaus Okkenhaug
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  Aberrant T cell differentiation in the absence of Dicer.

Authors:  Stefan A Muljo; K Mark Ansel; Chryssa Kanellopoulou; David M Livingston; Anjana Rao; Klaus Rajewsky
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

7.  A role for Dicer in immune regulation.

Authors:  Bradley S Cobb; Arnulf Hertweck; James Smith; Eric O'Connor; Daniel Graf; Terence Cook; Stephen T Smale; Shimon Sakaguchi; Frederick J Livesey; Amanda G Fisher; Matthias Merkenschlager
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

8.  The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.

Authors:  Sokol Haxhinasto; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2008-02-18       Impact factor: 14.307

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  43 in total

1.  Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.

Authors:  E Ilker Ozay; Sudarvili Shanthalingam; Joe A Torres; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

2.  Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.

Authors:  Yan Zhao; Kai Zhang; Haifeng Jiang; Jiang Du; Zong Na; Wei Hao; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

3.  Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.

Authors:  Francesca Lovat; Giovanni Nigita; Rosario Distefano; Tatsuya Nakamura; Pierluigi Gasparini; Luisa Tomasello; Paolo Fadda; Narmin Ibrahimova; Silvia Catricalà; Alexey Palamarchuk; Michael A Caligiuri; Anna Gallì; Luca Malcovati; Mark D Minden; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-18       Impact factor: 11.205

4.  miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.

Authors:  Yunjie Lu; Keli L Hippen; Amanda L Lemire; Jian Gu; Weizhi Wang; Xuhao Ni; Parvathi Ranganathan; Bruce L Levine; James L Riley; Carl H June; Laurence A Turka; David H Munn; Ramiro Garzon; Ling Lu; Bruce R Blazar
Journal:  Blood       Date:  2016-08-02       Impact factor: 22.113

5.  MicroRNA regulation of CD8+ T cell responses.

Authors:  John D Gagnon; K Mark Ansel
Journal:  Noncoding RNA Investig       Date:  2019-08-26

Review 6.  mTOR signaling in the differentiation and function of regulatory and effector T cells.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Curr Opin Immunol       Date:  2017-05-20       Impact factor: 7.486

7.  Knockout of both miR-15/16 loci induces acute myeloid leukemia.

Authors:  Francesca Lovat; Matteo Fassan; Diana Sacchi; Parvathi Ranganathan; Alexey Palamarchuk; Marius Bill; Malith Karunasiri; Pierluigi Gasparini; Giovanni Nigita; Rosario Distefano; Dario Veneziano; Adrienne M Dorrance; Ramiro Garzon; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-26       Impact factor: 11.205

Review 8.  Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.

Authors:  Martha de Oliveira Bravo; Juliana Lott Carvalho; Felipe Saldanha-Araujo
Journal:  Purinergic Signal       Date:  2016-08-25       Impact factor: 3.765

9.  Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells.

Authors:  Yogesh Singh; Yuetao Zhou; Xiaolong Shi; Shaqiu Zhang; Anja T Umbach; Madhuri S Salker; Karl S Lang; Florian Lang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

Review 10.  Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.

Authors:  Ye Shu; Qinghua Hu; Hai Long; Christopher Chang; Qianjin Lu; Rong Xiao
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.